Option Care Health

Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Option Care Health surpasses Q4 expectations, eyes growth opportunities

Option Care Health's Q4 performance reflects growth and resilience amidst inflation challenges. The company's financial strength, focus on efficiency, and strategic initiatives position it well for future expansion and value creation.

Option Care Health reports robust Q2 earnings amidst strategic growth focus

Option Care Health's Q2 2023 earnings call highlighted strong financial performance, with revenue growth and adjusted EBITDA exceeding expectations. The company's strategic initiatives focus on innovation, operational efficiency, and patient care excellence.
While facing challenges like reimbursement issues and cost pressures, Option Care Health remains optimistic about sustainable growth and shareholder value. Investments in capabilities and network expansion position the company for future opportunities.
Analysts' inquiries into revenue growth composition, cost challenges, and future outlooks were addressed with a focus on operational excellence and sustainable growth. Option Care Health's performance reflects a balance of financial strength and strategic vision.

Option Care Health excels in Q3 performance and eyes M&A for growth

Option Care Health's Q3 earnings call highlighted strong financial performance, successful collaboration, and strategic focus on M&A for shareholder value. Challenges include revenue pressure in Q4 and sustainability of procurement benefits for 2024 projections.

Option Care Health exceeds revenue expectations, eyes strategic growth

Option Care Health's strong financial performance in 2023 positions the company for continued growth.
Strategic initiatives, operational efficiencies, and engagement with payers highlight the company's resilience.
Navigating market dynamics, optimizing procurement benefits, and strategic growth remain key focus areas for 2024.

Option Care Health reports resilient Q1 performance and growth opportunities

Option Care Health's Q1 2024 performance showcased revenue growth, strong patient satisfaction, and resilience in maintaining financial strength.
Despite challenges from the cybersecurity incident and supply chain disruptions, the company remains focused on growth and operational improvements.
Opportunities lie in expanding services, portfolio diversification, and adapting to evolving patient needs for continued success in 2024.
With disciplined SG&A management and a commitment to patient care, Option Care Health is poised for growth and service expansion.

Option Care Health excels in Q2, boosts revenue outlook

Option Care Health's Q2 performance reflects resilience and strategic focus, driving revenue growth and operational efficiency.
Despite challenges, the company's strengths in financial management and capital deployment position it well for future opportunities.
With increased revenue expectations and a strong cash flow rebound, Option Care Health is poised for sustained growth and value creation.

Option Care Health reports resilient Q3 performance amid operational challenges

Option Care Health's Q3 2024 performance showcased growth and financial resilience amidst operational challenges.
The company's strategic focus on managing costs and pursuing growth initiatives positions it well to address upcoming gross margin pressures.
Despite facing headwinds, Option Care Health remains optimistic about its revenue outlook for the full year 2024 and beyond.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has sold 13.0 million shares of Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH) common stock in an underwritten secondary offering and, subject to completion of the offering, a concurrent share repurchase by OPCH in the amount of approximately 2.5 million shares.

Walgreens Boots Alliance Sells 15.5 Million Shares of Option Care Health

BANNOCKBURN, Ill., March 01, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell 13,000,000 shares of the Company's common stock at a price to the public of $30.75 per share in an underwritten secondary offering. The offering is expected to close on March 3, 2023, subject to customary closing conditions. The Company will not receive any proceeds from the offering.

Option Care Health Announces Pricing of Secondary Offering of 13,000,000 Shares of Common Stock and Common Stock Repurchase

BANNOCKBURN, Ill., March 01, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell 13,000,000 shares of the Company's common stock in an underwritten secondary offering. The Company will not receive any proceeds from the offering.

Option Care Health Announces Secondary Offering of 13,000,000 Shares of Common Stock and Common Stock Repurchase

Option Care Health, Inc. (NASDAQ:OPCH ) Q4 2022 Earnings Conference Call February 23, 2022 8:30 AM ET Company Participants Michael Shapiro - CFO & SVP John Rademacher - CEO, President & Director Conference Call Participants David MacDonald - Truist Securities Matthew Larew - William Blair Lisa Gill - JPMorgan Pito Chickering - Deutsche Bank Jamie Perse - Goldman Sachs Joanna Gajuk - Bank of America Operator Hello, and thank you for standing by. Welcome to Option Care Health Fourth Quarter 2022 Earnings Conference Call.

Option Care Health, Inc. (OPCH) Q4 2022 Earnings Call Transcript

Option Care (OPCH) delivered earnings and revenue surprises of 18.18% and 0.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) Surpasses Q4 Earnings and Revenue Estimates

BANNOCKBURN, Ill., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2022.

Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2022 and Announces Share Repurchase Authorization

BANNOCKBURN, Ill., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year ended December 31, 2022 on Thursday, February 23, 2023 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call

Addus HomeCare

LifeStance Health Group

Pennant Group Inc

Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. OPCH, LFST, ADUS and PNTG are well poised to gain from the prospects.

4 Stocks to Watch Amid a Challenging Outpatient Home Health Industry

BANNOCKBURN, Ill., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 in San Francisco. John Rademacher, Chief Executive Officer, and Mike Shapiro, Chief Financial Officer, are scheduled to present at 9:00am PT.

Option Care Health To Present At The 41st Annual J.P. Morgan Healthcare Conference

OVERLAND PARK, Kan.--( BUSINESS WIRE )--WellSky, a leading health and community care technology company, today announced it is significantly expanding its partnership with Option Care Health Inc. (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services. Option Care Health will collaborate with WellSky to accelerate innovations and workflow enhancements within WellSky's infusion and specialty pharmacy platform, CareTend®, and will implement the software across its more than 160 Option Care Health locations.

Option Care Health Expands Partnership With WellSky® to Accelerate Innovation in Home and Ambulatory Infusion Technology

Option Care Health, Inc. (NASDAQ:OPCH ) Q3 2022 Earnings Conference Call October 27, 2022 8:30 AM ET Company Participants Michael Shapiro - CFO & SVP John Rademacher - CEO, President & Director Conference Call Participants Matthew Larew - William Blair Lisa Gill - JPMorgan David MacDonald - Truist Securities Kieran Ryan - Deutsche Bank Joanna Gajuk - Bank of America Jamie Perse - Goldman Sachs Michael Petusky - Barrington Research Operator Good day and thank you for standing by. Welcome to the Option Care Health Third Quarter 2022 Earnings Conference Call.

Option Care Health, Inc. (OPCH) Q3 2022 Results - Earnings Call Transcript

Option Care (OPCH) delivered earnings and revenue surprises of 0% and 2.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) Q3 Earnings Match Estimates

BANNOCKBURN, Ill., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced financial results for the third quarter ended September 30, 2022.

Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2022

BANNOCKBURN, Ill., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2022 on Thursday, October 27, 2022 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health to Announce Third Quarter 2022 Financial Results and Host Conference Call

Option Care (OPCH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Option Care (OPCH) Stock Jumps 8.9%: Will It Continue to Soar?

DEERFIELD, Ill.--(BUSINESS WIRE)--WBA announced it has sold 11.0 million shares of Option Care Health, Inc. (Nasdaq: OPCH) common stock at a price to the public of $33.01 per share

Walgreens Boots Alliance Sells 11 Million Shares of Option Care Health

BANNOCKBURN, Ill., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell 11,000,000 shares of the Company's common stock at a price to the public of $33.25 per share in an underwritten secondary offering. The offering is expected to close on August 18, 2022, subject to customary closing conditions. The Company will not receive any proceeds from the offering.

Option Care Health Announces Pricing of Secondary Offering of 11,000,000 Shares of Common Stock

BANNOCKBURN, Ill., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell 11,000,000 shares of the Company's common stock in an underwritten secondary offering. The Company will not receive any proceeds from the offering.

Option Care Health Announces Secondary Offering of 11,000,000 Shares of Common Stock

Option Care Health posted a robust set of quarterly earnings last month, with upsides in revenue relative to consensus. The company continues to exhibit quality characteristics of growing NOPAT, high single-digit ROIC and ~7.7% free cash flow ROE.

Option Care Health: Trigger Heavy On This Long-Term Cash Compounder

Option Care Health, Inc. (NASDAQ:OPCH ) Q2 2022 Earnings Conference Call July 27, 2022 8:30 AM ET Company Participants Michael Shapiro - CFO & SVP John Rademacher - CEO, President & Director Conference Call Participants Lisa Gill - JPMorgan Chase & Co. David MacDonald - Truist Securities Matthew Larew - William Blair & Company Joanna Gajuk - Bank of America Merrill Lynch Philip Chickering - Deutsche Bank Operator Good day, and thank you for standing by. Welcome to the Option Care Health 2022 Earnings Conference Call.

Option Care Health, Inc. (OPCH) CEO John Rademacher on Q2 2022 Results - Earnings Call Transcript

Option Care (OPCH) delivered earnings and revenue surprises of -13.64% and 3.99%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) Misses Q2 Earnings Estimates

BANNOCKBURN, Ill., July 27, 2022 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced financial results for the second quarter ended June 30, 2022.

Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2022

BANNOCKBURN, Ill., June 30, 2022 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2022 on Wednesday, July 27, 2022 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health to Announce Second Quarter 2022 Financial Results and Host Conference Call

Option Care (OPCH) Stock Jumps 5.6%: Will It Continue to Soar?

Cirrus Logic

Helen of Troy

SYNNEX

Avnet

Science Applications International

Finding value is challenging in this difficult market environment but when you do, those are the best stocks to buy. The post The 7 Best Stocks to Buy for June 2022 appeared first on InvestorPlace.

News for Option Care Health Stock (OPCH)